Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex

@article{Pierce2004HallucinogenicDI,
  title={Hallucinogenic drug interactions with neurotransmitter receptor binding sites in human cortex},
  author={Pamela A. Pierce and Stephen J. Peroutka},
  journal={Psychopharmacology},
  year={2004},
  volume={97},
  pages={118-122}
}
The binding affinities of four hallucinogenic agents were analyzed at nine neurotransmitter binding sites in human cortex. d-Lysergic acid diethylamide (d-LSD), N,N-dimethyltryptamine (DMT), 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) and 1-(2,5-dimethoxy-4-bromophenyl)-2-aminopropane (DOB) display highest affinity for the recently identified “DOB binding site” labeled by 77Br-R(-)DOB. The phenalkylamines, DOI and DOB, display subnanomolar affinity for the 77Br-R(-)DOB-labeled site… Expand
Hallucinogen-Like Action of the Novel Designer Drug 25I-NBOMe and Its Effect on Cortical Neurotransmitters in Rats
TLDR
The data from this study suggest that hallucinogenic activity of 25I-NBOMe seems to be related with the increase in extracellular GLU level-mediated via cortical 5-HT2A receptors, and may modulate its effect on neurotransmitters and HTR. Expand
Monoamine receptor interaction profiles of 4-thio-substituted phenethylamines (2C-T drugs)
TLDR
The receptor binding profile of 2C-T drugs predicts psychedelic effects that are mediated by potent 5-HT2 receptor interactions, and these effects are sometimes sold as new psychoactive substances (NPSs). Expand
Receptor Interaction Profiles of 4-Alkoxy-Substituted 2,5-Dimethoxyphenethylamines and Related Amphetamines
TLDR
4-alkyloxy-substituted 2,5-dimethoxyamphetamines and Phenethylamines share some trends with the many other phenethylamine pharmacophore containing compounds, such as when increasing the size of the 4- substituent and increasing the lipophilicity, the affinities at the 5-HT2A/C subtype also increase, and only weak 5- HT2A or C subtype selectivities were achieved. Expand
Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
TLDR
The evidence demonstrating that the effects of indoleamine hallucinogens in a variety of animal behavioral paradigms are mediated by both 5-HT(2) and non-5-HT (2) receptors is reviewed. Expand
Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
TLDR
It is confirmed that psilocin acts as an agonist at 5-HT1A, 4-hydroxy-N,N-dimethyltryptamine, and 5- HT2C receptors in mice, whereas the behavioral effects of 1-methylpsilocin indicate that this compound is acting at5-HT2A sites but is inactive at the 5-ht1A receptor. Expand
Neurochemical and Behavioral Effects of a New Hallucinogenic Compound 25B-NBOMe in Rats
4-Bromo-2,5-dimethoxy-N-(2-methoxybenzyl)phenethylamine (25B-NBOMe) is a hallucinogen exhibiting high binding affinity for 5-HT 2A/C serotonin receptors. In the present work, we investigated itsExpand
Tolerance to neurochemical and behavioral effects of the hallucinogen 25I-NBOMe
TLDR
The findings suggest that multiple injections of 25I-NBOMe induce tolerance to hallucinogenic activity and produce alterations in neurotransmission and anxiety seems to be the result of complex interactions between neurotransmitter pathways. Expand
Towards a biophysical understanding of hallucinogen action
Braden, Michael Robert. Ph.D., Purdue University, May, 2007. Towards a Biophysical Understanding of Hallucinogen Action. Major Professor: David E. Nichols. The serotonin 2A (5-HT2A) receptor isExpand
The hallucinogenic world of tryptamines: an updated review
TLDR
A comprehensive update on tryptamine hallucinogens, concerning their historical background, prevalence, patterns of use and legal status, chemistry, toxicokinetics, toxicodynamics and their physiological and toxicological effects on animals and humans is provided. Expand
Agonistic Properties of Cannabidiol at 5-HT1a Receptors
TLDR
These studies demonstrate that CBD is a modest affinity agonist at the human 5-HT1a receptor, and indicate that cannabidiol may have interesting and useful potential beyond the realm of cannabinoid receptors. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 37 REFERENCES
Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents.
TLDR
The results of this study suggest that the mechanism of action of these agents involves 5-HT2-related events. Expand
Characterization of a novel 3H-5-hydroxytryptamine binding site subtype in bovine brain membranes
  • R. E. Heuring, S. Peroutka
  • Chemistry, Medicine
  • The Journal of neuroscience : the official journal of the Society for Neuroscience
  • 1987
TLDR
The data demonstrate the presence of a homogeneous class of 5- HT1 binding sites in bovine caudate that is pharmacologically distinct from previously defined 5-HT1A, 5-ht1B, 5 - HT1C, 4-HT2, 3-HT3 receptor subtypes. Expand
3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
TLDR
3H-DOB labels a subset of brain 5-HT2 receptors that has high affinity for agonists as well as antagonists); 3H-ketanserin appears to label both subsets ofbrain 5- HT2 receptors. Expand
R(−)-2,5-Dimethoxy-4-77bromoamphetamine [77Br-R(−)DOB]: a novel radioligand which labels a 5-HT binding site subtype
R(−)-2,5-Dimethoxy-4-77Br-amphetamine [77Br-R(−)DOB], a radioligand of high specific activity (1500±200 Ci/mmol), was used to label membrane-associated recognition sites in rat brain. 77Br-R(−)DOBExpand
Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists.
TLDR
The results of this study suggest that the discriminative stimulus effects of DOM, the three hallucinogenic agents to which DOM-stimulus generalization occurred, and quipazine, may involve those sub-populations of serotonin receptors that are labeled by tritiated ketanserin (i.e. 5-HT2 sites). Expand
Action of psychotogenic drugs on single midbrain raphe neurons.
TLDR
The results indicate that the indole and phenethylamine psychotogens, which have similar effects on behavior, also have an overlapping although not identical effect on single units in the raphe nuclei. Expand
Psychotomimetic drugs and brain 5-hydroxytryptamine metabolism
The effects of indolealkylamine and phenylethylamine psychotomimetic drugs on brain 5-hydroxytryptamine (5-HT) metabolism have been studied. Indolealkylamines (psilocybin, psilocin,Expand
Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol.
TLDR
It is proposed that [3H]5-HT and[3H]-spiroperidol label distinct populations of serotonin receptors in rat brain, designated 5-HT1 and 5- HT2 receptors, respectively. Expand
Nerve terminal effects of indoleamine psychotomimetics on 5-hydroxytryptamine
  • A. Halaris
  • Medicine, Chemistry
  • Neuroscience & Biobehavioral Reviews
  • 1983
TLDR
It was concluded that an intact nerve terminal is necessary for the expression of the LSD-mediated increases in 5-HT, and a LSD "autoreceptor" is postulated, possibly identical to a 5- HT presynaptic receptor inhibiting the release of5-HT. Expand
Effects of the phenethylamine derivatives, BL-3912, fenfluramine, and Sch-12679, in rats trained with LSD as a discriminative stimulus
TLDR
A variety of drugs may substitute in whole or in part for LSD in LSD-trained rats, and even complete substitution of a drug forLSD in the rat is not necessarily associated with the production by that drug of hallucinations in man. Expand
...
1
2
3
4
...